Laser treatment of acne

Lancet

Volumn 362, Issue 9393, 2003, Pages 1342-

  Webster, Guy F ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BENZOYL PEROXIDE; DOXYCYCLINE FOSFATEX; ISOTRETINOIN; MINOCYCLINE; RETINOID;

ACNE; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BACTERICIDAL ACTIVITY; DRUG INDUSTRY; HEALTH ECONOMICS; HUMAN; IMMUNE SYSTEM; KERATINIZATION; LOW LEVEL LASER THERAPY; NOTE; PATIENT ATTITUDE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROPIONIBACTERIACEAE; PULSED DYE LASER; SEBACEOUS GLAND;

EID: 0242285688     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14670-3     Document Type: Note

References (6)

1. Kligman A.M. An overview of acne. J Invest Dermatol. 62:1974;268-287.
2. Webster G.F. Acne vulgaris. BMJ. 325:2002;475-479.
3. Leyden J.J. The evolving role of Propionibacterium acnes in acne. Semin Cutan Med Surg. 20:2001;139-143.
4. Kim J., Ochoa M.T., Krutzik S.R., et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 169:2002;1535-1541.
5. Shalita A.R. The integral role of topical and oral retinoids in the early treatment of acne. J Eur Acad Dermatol Venereol. 15:2001;43-49.
6. Thiboutot D. New treatments and therapeutic strategies for acne. Arch Fam Med. 9:2000;179-187.